Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hero Technologies Inc. stock logo
HENC
Hero Technologies
$0.00
$0.00
$0.01
N/A1.081,900 shsN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
$0.00
$0.00
$0.21
$36KN/A26,223 shs2,000 shs
One Bio Corp. stock logo
ONBI
One Bio
$0.00
$0.00
$0.00
$0.01
N/A-4.27N/AN/A
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
$0.00
$0.00
$0.00
$0.02
$10K3.2112 shs1,134 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hero Technologies Inc. stock logo
HENC
Hero Technologies
0.00%0.00%0.00%0.00%-97.87%
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
0.00%0.00%0.00%0.00%0.00%
One Bio Corp. stock logo
ONBI
One Bio
0.00%0.00%0.00%-93.33%-93.33%
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
0.00%0.00%+200.00%0.00%-97.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hero Technologies Inc. stock logo
HENC
Hero Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/AN/AN/AN/AN/AN/AN/A
One Bio Corp. stock logo
ONBI
One Bio
N/AN/AN/AN/AN/AN/AN/AN/A
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hero Technologies Inc. stock logo
HENC
Hero Technologies
0.00
N/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
0.00
N/AN/AN/A
One Bio Corp. stock logo
ONBI
One Bio
0.00
N/AN/AN/A
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hero Technologies Inc. stock logo
HENC
Hero Technologies
N/AN/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/AN/AN/AN/AN/A
One Bio Corp. stock logo
ONBI
One Bio
N/AN/AN/AN/AN/AN/A
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
N/AN/AN/AN/A($0.58) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hero Technologies Inc. stock logo
HENC
Hero Technologies
-$540KN/A0.00N/AN/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/A0.00N/AN/AN/AN/AN/AN/A
One Bio Corp. stock logo
ONBI
One Bio
N/AN/A0.00N/AN/AN/AN/AN/A
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
-$4.72M-$0.11N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hero Technologies Inc. stock logo
HENC
Hero Technologies
N/AN/AN/AN/AN/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/AN/AN/AN/AN/A
One Bio Corp. stock logo
ONBI
One Bio
N/AN/AN/AN/AN/A
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Hero Technologies Inc. stock logo
HENC
Hero Technologies
N/A
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/A
One Bio Corp. stock logo
ONBI
One Bio
N/A
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
N/A

Insider Ownership

CompanyInsider Ownership
Hero Technologies Inc. stock logo
HENC
Hero Technologies
0.21%
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
N/A
One Bio Corp. stock logo
ONBI
One Bio
N/A
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
1.44%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hero Technologies Inc. stock logo
HENC
Hero Technologies
1456.69 million455.73 millionNot Optionable
NephroGenex, Inc stock logo
NRXGQ
NephroGenex
1,70012.95 millionN/ANot Optionable
One Bio Corp. stock logo
ONBI
One Bio
360N/AN/ANot Optionable
NovAccess Global Inc. stock logo
XSNX
NovAccess Global
244.60 million43.96 millionNot Optionable

Recent News About These Companies

Global wage calculator: Compare your salary
NovAccess Global Inc.
NovAccess Global Inc. (XSNX)
NovAccess Global Announces $10.7 Million Financing
Novaccess Global Inc XSNX

Media Sentiment Over Time

Hero Technologies stock logo

Hero Technologies OTCMKTS:HENC

Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company is based in Dover, Delaware.

NephroGenex stock logo

NephroGenex OTCMKTS:NRXGQ

NephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.

One Bio stock logo

One Bio OTCMKTS:ONBI

$0.0002 0.00 (0.00%)
As of 07/3/2025

ONE Bio Corp., an agritech company, together with its subsidiaries, utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements, and organic products. The company operates through two business units, Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE business unit engages in the development, manufacture, and commercialization of bio-ecological products and over-the-counter products utilizing the extractions of tobacco leaves and various other plant materials. It produces chemical and herbal extracts for use in a range of health and wellness products, including chemical extracts comprising Solanesol and Coenzyme Q10; and herabal extracts, such as Resveratrol, 5-Hydroxytryptophan, Ganoderma Tea, and powdered and particulate fertilizers. This business unit distributes its products through independent third party distributors, universities, and hospital research centers to the bio-health industry and raw chemical intermediates industry in the People's Republic of China. The OP business unit manufactures various consumer and commercial use health and energy drinks, organic food products, and fertilizers primarily based on bamboo in the People's Republic of China. Its products include boiled bamboo shoot cans, boiled bamboo shoot cans with vacuum packing, boiled mixed vegetables, and boiled seasoned vegetables, as well as Kamameshi, a Japanese rice dish. This segment distributes its products directly to supermarket chains, hotels, hospitals, and restaurants, as well as through a network of independent third party distributors. ONE Bio Corp. exports its products to Japan, southeast Asia, Europe, and North America. The company was formerly known as ONE Holdings, Corp. and changed its name to ONE Bio Corp. in November 2009. ONE Bio Corp. was incorporated in 2000 and is headquartered in Aventura, Florida.

NovAccess Global stock logo

NovAccess Global OTCMKTS:XSNX

$0.0003 0.00 (0.00%)
As of 02:51 PM Eastern

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.